499
Views
29
CrossRef citations to date
0
Altmetric
Clinical Features - Original Research

Calprotectin levels in rheumatoid arthritis and their correlation with disease activity: a meta-analysis

&
Pages 531-537 | Received 09 Jan 2017, Accepted 12 Apr 2017, Published online: 24 Apr 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Michael Mahler, Pier-Luigi Meroni, Maria Infantino, Katherine A. Buhler & Marvin J. Fritzler. (2021) Circulating Calprotectin as a Biomarker of COVID-19 Severity. Expert Review of Clinical Immunology 17:5, pages 431-443.
Read now
Anders Larsson, Jonas Tydén, Joakim Johansson, Miklos Lipcsey, Maria Bergquist, Kim Kultima & Aleksandra Mandic-Havelka. (2020) Calprotectin is superior to procalcitonin as a sepsis marker and predictor of 30-day mortality in intensive care patients. Scandinavian Journal of Clinical and Laboratory Investigation 80:2, pages 156-161.
Read now
Casandra Buzatu & Robert J. Moots. (2019) Measuring disease activity and response to treatment in rheumatoid arthritis. Expert Review of Clinical Immunology 15:2, pages 135-145.
Read now

Articles from other publishers (26)

Kajetan Kiełbowski, Wiktoria Stańska, Estera Bakinowska, Marcin Rusiński & Andrzej Pawlik. (2024) The Role of Alarmins in the Pathogenesis of Rheumatoid Arthritis, Osteoarthritis, and Psoriasis. Current Issues in Molecular Biology 46:4, pages 3640-3675.
Crossref
Merve Gokcen Polat, Ahmet Omma, Neslihan Gokcen, Muhammed Fevzi Kilinckaya & Selma Ozkan Karaahmetoglu. (2024) Role of serum calprotectin in identifying familial Mediterranean fever attacks. Irish Journal of Medical Science (1971 -).
Crossref
E. P. Kolesova, D. A. Usoltsev, E. V. Moguchaia, M. A. Boyarinova, A. M. Erina, K. M. Tolkunova, A. L. Maslyanskiy, A. V. Mazing, S. V. Kibkalo, E. Yu. Vasileva, N. S. Novikova, E. I. Ermolenko, N. N. Artemov, O. P. Rotar, A. O. Konradi & E. V. Shlyakhto. (2023) Association of fecal zonulin and calprotectin levels with cardiovascular risk factors and target organ damage in a sample of patients with metabolic disorders. Russian Journal of Cardiology 28:11, pages 5569.
Crossref
Beatriz Frade-Sosa, Chafik Alejandro Chacur, Josep M. Augé, Andrés Ponce, Juan C. Sarmiento-Monroy, Ana Belén Azuaga, Nuria Sapena, Julio Ramírez, Virginia Ruiz-Esquide, Rosa Morlà, Sandra Farietta, Patricia Corzo, Juan D. Cañete, Raimon Sanmartí & José A. Gómez-Puerta. (2023) Calprotectin in Patients with Rheumatic Immunomediated Adverse Effects Induced by Checkpoints Inhibitors. Cancers 15:11, pages 2984.
Crossref
Christina Heidt, Ulrike Kämmerer, Manfred Fobker, Andreas Rüffer, Thorsten Marquardt & Monika Reuss-Borst. (2023) Assessment of Intestinal Permeability and Inflammation Bio-Markers in Patients with Rheumatoid Arthritis. Nutrients 15:10, pages 2386.
Crossref
Mariangela Manfredi, Lieve Van Hoovels, Maurizio Benucci, Riccardo De Luca, Carmela Coccia, Pamela Bernardini, Edda Russo, Amedeo Amedei, Serena Guiducci, Valentina Grossi, Xavier Bossuyt, Carlo Perricone & Maria Infantino. (2023) Circulating Calprotectin (cCLP) in autoimmune diseases. Autoimmunity Reviews 22:5, pages 103295.
Crossref
Leszek Roszkowski, Bożena Jaszczyk, Magdalena Plebańczyk & Marzena Ciechomska. (2022) S100A8 and S100A12 Proteins as Biomarkers of High Disease Activity in Patients with Rheumatoid Arthritis That Can Be Regulated by Epigenetic Drugs. International Journal of Molecular Sciences 24:1, pages 710.
Crossref
José Inciarte-Mundo, Beatriz Frade-Sosa & Raimon Sanmartí. (2022) From bench to bedside: Calprotectin (S100A8/S100A9) as a biomarker in rheumatoid arthritis. Frontiers in Immunology 13.
Crossref
A. A. Korolkova, V. V. Khizha, D. I. Kozlova, A. L. Maslyanskiy & T. V. Vavilova. (2022) Сalprotectin in the blood plasma as a new biomarker for assessing the activity of rheumatoid arthritis. Bulletin of Siberian Medicine 21:3, pages 59-66.
Crossref
Isaac T. Cheng, Huan Meng, Martin Li, Edmund K. Li, Priscilla C. Wong, Jack Lee, Bryan P. Yan, Alex P. W. Lee, Ho So & Lai-Shan Tam. (2022) Serum Calprotectin Level Is Independently Associated With Carotid Plaque Presence in Patients With Psoriatic Arthritis. Frontiers in Medicine 9.
Crossref
Mona H. Abd Elsamea, Safaa A. Mahran, Asmaa N. Badr, Dalia T. Kamal & Tayseer M. Khidre. (2022) Evaluation of serum calprotectin level as a biomarker of disease activity in rheumatoid arthritis and osteoarthritis patients. The Egyptian Rheumatologist 44:3, pages 185-190.
Crossref
Maurizio Benucci. (2021) Serum calprotectin: emerging marker of rheumatoid arthritis. Beyond Rheumatology 3:2.
Crossref
Leszek Roszkowski & Marzena Ciechomska. (2021) Tuning Monocytes and Macrophages for Personalized Therapy and Diagnostic Challenge in Rheumatoid Arthritis. Cells 10:8, pages 1860.
Crossref
Marnix Mylemans, Louis Nevejan, Stefanie Van Den Bremt, Muriel Stubbe, Bert Vander Cruyssen, Christina Moulakakis, Heike Berthold, Christian Konrad, Xavier Bossuyt & Lieve Van Hoovels. (2021) Circulating calprotectin as biomarker in neutrophil-related inflammation: Pre-analytical recommendations and reference values according to sample type. Clinica Chimica Acta 517, pages 149-155.
Crossref
Attila Balog, Borisz Varga, Ferenc Fülöp, Ildikó Lantos, Gergely Toldi, László Vécsei & Yvette Mándi. (2021) Kynurenic Acid Analog Attenuates the Production of Tumor Necrosis Factor-α, Calgranulins (S100A 8/9 and S100A 12), and the Secretion of HNP1–3 and Stimulates the Production of Tumor Necrosis Factor-Stimulated Gene-6 in Whole Blood Cultures of Patients With Rheumatoid Arthritis. Frontiers in Immunology 12.
Crossref
Maria INFANTINO & Mariangela MANFREDI. (2021) La calprotectina sierica: marcatore emergente di artrite reumatoide. La Rivista Italiana della Medicina di Laboratorio 17:1.
Crossref
Ahmed R. Radwan, Ahmed Allam & Abdullah Radwan. (2021) The relationship of serum calprotectin with disease activity, functional status, ultrasonographic findings and radiological damage in rheumatoid arthritis patients. The Egyptian Rheumatologist 43:2, pages 147-151.
Crossref
Matthias Jarlborg, Delphine S. Courvoisier, Céline Lamacchia, Laura Martinez Prat, Michael Mahler, Chelsea Bentow, Axel Finckh, Cem Gabay & Michael J. Nissen. (2020) Serum calprotectin: a promising biomarker in rheumatoid arthritis and axial spondyloarthritis. Arthritis Research & Therapy 22:1.
Crossref
Carlos M. Laborde, Patricia Castro-Santos & Roberto Díaz-Peña. (2020) Contribution of Multiplex Immunoassays to Rheumatoid Arthritis Management: From Biomarker Discovery to Personalized Medicine. Journal of Personalized Medicine 10:4, pages 202.
Crossref
Lieve Van Hoovels, Bert Vander Cruyssen, Laura Bogaert, Stefanie Van den Bremt & Xavier Bossuyt. (2019) Pre-analytical and analytical confounders of serum calprotectin as a biomarker in rheumatoid arthritis. Clinical Chemistry and Laboratory Medicine (CCLM) 58:1, pages 40-49.
Crossref
Qin Wang, Weiqian Chen & Jin Lin. (2019) The role of calprotectin in rheumatoid arthritis. Journal of Translational Internal Medicine 7:4, pages 126-131.
Crossref
Emma C. de Moel, Jürgen Rech, Michael Mahler, Johannes Roth, Thomas Vogl, Anne Schouffoer, Robbert J. Goekoop, Tom W. J. Huizinga, Cornelia F. Allaart, René E. M. Toes, Georg Schett & Diane van der Woude. (2019) Circulating calprotectin (S100A8/A9) is higher in rheumatoid arthritis patients that relapse within 12 months of tapering anti-rheumatic drugs. Arthritis Research & Therapy 21:1.
Crossref
Günther A. Rezniczek, Claudia Förster, Ziad Hilal, Timm Westhoff & Clemens B. Tempfer. (2019) Calprotectin in pregnancy and pregnancy-associated diseases: a systematic review and prospective cohort study. Archives of Gynecology and Obstetrics 299:6, pages 1567-1577.
Crossref
Santiago Muñoz-Fernández, Teresa Otón-Sánchez, Loreto Carmona, Jaime Calvo-Alén, Alejandro Escudero, Javier Narváez, Jose Manuel Rodríguez Heredia, Susana Romero Yuste, Paloma Vela, Sara Luján Valdés, Ana Royo García & José Luis Baquero. (2018) Use of prognostic factors of rheumatoid arthritis in clinical practice and perception of their predictive capacity before and after exposure to evidence. Rheumatology International 38:12, pages 2289-2296.
Crossref
Lise Pedersen, Erling Birkemose, Charlotte Gils, Sara Safi & Mads Nybo. (2018) Sample Type and Storage Conditions Affect Calprotectin Measurements in Blood. The Journal of Applied Laboratory Medicine 2:6, pages 851-856.
Crossref
Lieke Tweehuysen, Nathan den Broeder, Noortje van Herwaarden, Leo A B Joosten, Peter L van Lent, Thomas Vogl, Frank H J van den Hoogen, Rogier M Thurlings & Alfons A den Broeder. (2018) Predictive value of serum calprotectin (S100A8/A9) for clinical response after starting or tapering anti-TNF treatment in patients with rheumatoid arthritis. RMD Open 4:1, pages e000654.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.